Loading company…
UpFront Diagnostics develops blood tests to detect large vessel occlusion strokes.
Founded in 2017 and based in Cambridge, UK, UpFront Diagnostics develops LVOne, a biomarker test designed to detect large vessel occlusion strokes within 15 minutes using a finger-prick blood sample. In May 2025, it raised an undisclosed amount from Phoenix Sustainable Investments and Cambridge Enterprise. The company plans to pursue US regulatory approval, begin commercialization in the UK and Europe, and expand research and development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in